promazine has been researched along with Basal Ganglia Diseases in 4 studies
Promazine: A phenothiazine with actions similar to CHLORPROMAZINE but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic.
promazine : A phenothiazine deriative in which the phenothiazine tricycle has a 3-(dimethylaminopropyl) group at the N-10 position.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gardos, G | 1 |
| Cole, JO | 1 |
| Marcotte, DB | 1 |
| Snyder, SH | 1 |
| Greenberg, D | 1 |
| Yamumura, HI | 1 |
| Hertrich, O | 1 |
1 review available for promazine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Maintenance antipsychotic therapy: is the cure worse than the disease?
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Chronic Disease; Clinical Trials as To | 1976 |
1 trial available for promazine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Maintenance antipsychotic therapy: is the cure worse than the disease?
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Chronic Disease; Clinical Trials as To | 1976 |
3 other studies available for promazine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Neuroleptics and neurologic reactions.
Topics: Adolescent; Adult; Antipsychotic Agents; Athetosis; Basal Ganglia Diseases; Female; Humans; Mesorida | 1973 |
Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Binding, Competitive; Brain; Chlorpromazine; | 1974 |
[Neuroleptics, thymoleptics and tranquilizers in neurological therapy].
Topics: Basal Ganglia Diseases; Chlordiazepoxide; Chlorpromazine; Diazepam; Epilepsy; Extrapyramidal Tracts; | 1969 |